Immunotherapy in Cancer Treatment

This session focuses on the latest advancements in immunotherapy for cancer treatment, including novel approaches, clinical trials, Immunotherapy has emerged as a ground-breaking approach in cancer treatment, offering new hope to patients by leveraging the power of the immune system to combat cancer. Unlike traditional treatments that directly target cancer cells, immunotherapy enhances the body's natural defences to identify and destroy cancer cells more effectively. One of the key strategies in immunotherapy is checkpoint inhibitors, which block inhibitory pathways in the immune system that cancer cells exploit to evade detection. By releasing these brakes, checkpoint inhibitors unleash the immune system to mount a more robust attack against cancer.Another promising approach is adoptive cell therapy, such as CAR-T cell therapy, which involves genetically modifying a patient's T cells to recognize and kill cancer cells. This personalized therapy has shown remarkable success, particularly in certain types of blood cancers.

    Related Conference of Immunotherapy in Cancer Treatment

    November 21-22, 2024

    11th World Congress on Epigenetics and Chromosome

    Dubai, UAE
    December 09-10, 2024

    17th World Congress on Stem Cell Research

    Dubai, UAE
    March 17-18, 2025

    8th Global Conference on Cell and Gene Therapy

    Paris, France
    June 16-17, 2025

    21st Global Summit on Stem Cell & Regenerative Medicine

    Frankfurt, Germany

    Immunotherapy in Cancer Treatment Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in